Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Pharmacokinetics: approximate terminal half-life 6 days, Cmax at 40-48 hours post-injection, steady-state in 4-5 weeks
Efficacy: What the Head-to-Head Trial Showed In the head-to-head 72-week SURMOUNT-5 trial of 751 adults with obesity without diabetes, tirzepatide reduced body weight by an average of about 20.2% versus 13.7% for semaglutide
These habits matter whether you're on tirzepatide or not
NOVO NORDISK TO SELL WEIGHT-LOSS DRUG FOR $499 TO ELIGIBLE CUSTOMERS Novo Nordisk is a Danish healthcare company that develops treatments for an array of illnesses, including diabetes and obesity drugs
US$ 25.74
US$ 24.62
US$ 26.74
US$ 23.87
